GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a remarkable shift in how we handle diabetes mellitus . These new therapies function to stimulating the body’s own GLP-1 substance , https://bookmarklayer.com/story21785256/glp-1-a-major-approach-in-blood-sugar-treatment